This course includes the recording of a live Instructional Course from the 2026 AOSSM Annual Meeting.
Please Note: The Q&A QR code in the Recording is currently inactive. Any questions submitted through it will not be monitored or answered.
IC 06-2026-Practice Surgical Augmentation Rotator Cuff Repair using Biologics
Course Description:
Despite significant advances in surgical technique, rotator cuff repair healing rates have remained stubbornly inconsistent. Persistent non-healing continues to challenge even the most experienced shoulder surgeons, prompting exploration of biologic, mechanical, and peri-operative strategies to optimize outcomes. This Instructional Course Lecture provides a practical, evidence-based framework for improving rotator cuff healing. The session begins with peri-operative optimization and modifiable risk factors before transitioning to a series of focused lectures on biologic and mechanical augmentation strategies. Faculty will present data and real-world experience with bone marrow aspirate concentrate (BMAC), platelet-rich plasma (PRP), enthesis and patch augmentation, microfragmented lipoaspirate tissue, and subacromial bursa reimplantation. The course concludes with a moderated interactive discussion to synthesize lessons learned and help attendees identify which strategies can be realistically integrated into their clinical practice today.
Learning Objectives:
By the end of this course, participants should be able to:
- At the conclusion of this session, participants will be able to apply evidence-based principles to select and incorporate biologic augmentation techniques during rotator cuff repair based on patient characteristics, tear pathology, and current clinical evidence.
Faculty:
- Augustus Mazzocca, MS, MD
- Scott Rodeo, MD
- Brian J. Cole, MD
- John M. Tokish, MD
- Pietro S. Randelli, MD
- James M. Gregory, MD
ACCREDITATION STATEMENT The American Orthopaedic Society for Sports Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
|
|
ABOS MOC CREDIT STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery’s (ABOS) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.
AMA CREDIT DESIGNATION STATEMENT The American Orthopaedic Society for Sports Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CLAIMING CREDIT In order to obtain AMA PRA Category 1 Credit™ participants must complete the activity and online evaluation. No hard copy submissions will be accepted.
American Orthopaedic Society for Sports Medicine (AOSSM) (BOC AP# P460) is approved by the Board of Certification, Inc. to provide continuing education to Athletic Trainers. This program is eligible for a maximum of 1 Category A CEUs. ATs should claim only those hours actually spent in the educational program.
|
| |
Augustus (Gus) D. Mazzocca, MD
Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Researcher (Ongoing)|restor3d: Consultant (Ongoing)|restor3d: Own stock options in a privately held ineligible company (Ongoing)
Scott A. Rodeo, MD
Advance Medical: Consultant (Ongoing)|Enovis: Consultant (Ongoing)|Overture: Own stock options in a privately held ineligible company (Ongoing)
Brian J. Cole, MD, MBA
Arthrex, Inc: Consultant (Ongoing)|Arthrex, Inc: Researcher (Ongoing)|Arthrex, Inc: Royalties (Ongoing)|Elsevier Publishing: Other (Ongoing)|Elsevier Publishing: Royalties (Ongoing)|National Institutes of Health (NIAMS & NICHD): Researcher (Ongoing)|Ossio: Own stock options in a privately held ineligible company (Ongoing)
John M. Tokish, MD
Arthrex Inc: Consultant (Ongoing), Researcher (Ongoing), Royalties (Ongoing)
Pietro S. S. Randelli, MD
"has no relevant financial relationship(s) with ineligible companies to disclose"
James M. Gregory, MD
Stryker: Consultant and Researcher (ongoing); Arthrex: Researcher
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, we have implemented measures to identify and mitigate relevant financial relationships. All individuals in control of content have disclosed their financial relationships with ineligible companies within the past 24 months. These relationships have been reviewed and mitigated.
ORIGINAL RELEASE DATE: 8/1/2026
EXPIRATION DATE: 7/31/2029